The global Cardiac Pacemaker Market Growth Accelerated by Rising Prevalence of Cardiovascular Diseases


 Cardiac pacemakers are medical devices that are implanted to regulate abnormal heart rhythms and control heart rate using electrical pulses. They are used to treat arrhythmias such as bradycardia, which is a slow or irregular heartbeat that cannot pump enough blood to the body. Cardiac pacemakers help improve the quality of life for millions of people by regulating heartbeat and preventing abnormal rhythms that can be fatal.

The global Cardiac Pacemaker Market is estimated to be valued at US$ 4.5 billion in 2023 and is expected to exhibit a CAGR of 3% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The rising prevalence of cardiovascular diseases is the primary factor driving the growth of the cardiac pacemaker market. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. Risk factors of cardiovascular diseases such as obesity, physical inactivity and diabetes are on the rise. This has significantly increased the number of patients requiring pacemaker implantation. Moreover, technological advancements are leading to the development of advanced pacemakers that are more effective and long-lasting. The emergence of wireless pacemakers with features such as remote monitoring capability allow for better disease management and post-operative care, thereby accelerating the market growth.

Segment Analysis

The global cardiac pacemaker market is dominated by single-chamber pacemakers segment. Single-chamber pacemakers account for over 70% of total pacemaker implants globally owing to their low cost and ability to treat most common bradycardia conditions effectively. Dual-chamber pacemakers are the fastest growing segment however due to better synchronization of heart chambers during pacing and fewer complications compared to single-chamber devices. Implantable cardioverter defibrillators (ICDs) are another major segment in the market though indications for ICDs are more limited to treatment of lethal arrhythmias.

Key Takeaways

The global cardiac pacemaker market is expected to witness high growth. Factors such as increasing geriatric population, rising prevalence of cardiovascular & lifestyle diseases and technological advancements in pacemaker devices are driving the market expansion.

Regional analysis: North America currently leads the cardiac pacemaker market due to favourable reimbursement policies and growing awareness about cardiac devices. However, Asia Pacific region is emerging as the fastest growing market with China, India and Japan being the major revenue generators. Increasing healthcare spending, growing medical tourism and rising incidence of heart diseases are augmenting the demand for pacemakers in Asia Pacific.

Key players: Key players operating in the cardiac pacemaker market are Medtronic, Abbott, BIOTRONIK, Boston Scientific, Lepu Medical, MEDICO, OSYPKA, Pacetronix and Shree Pacetronix. Medtronic dominates the global market with over 45% share due to wide product portfolio and strong distribution network across regions. Other major players include Abbott, BIOTRONIK and Boston Scientific. 

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more